Máj- és epeúti rák: vizsgálatok itt: Kína
621 trials · From ClinicalTrials.gov, checked 2026. november 18.. Ask the study team whether a trial fits you.
- 2. fázisTaking peopleLenvatinib, Tislelizumab Combined With RALOX Regimen HAIC in Advanced Hepatocellular Carcinoma
- Where
- Guangzhou
- Életkor
- 18 év and over
- People
- 29
- Run by
- Guangdong Provincial People's Hospital
See details and how to joinNCT05954897 - No phaseTaking peopleGPC3-directed CAR-T in the Treatment Amongst Subjects With Advanced Hepatocellular Carcinoma
- Where
- Shanghai
- Életkor
- 18 év to 75 év
- People
- 12
- Run by
- RenJi Hospital
See details and how to joinNCT05926726 - 2. fázisTaking peoplePhase 2 Study of SBRT Plus Tislelizumab and Regorafenib in Unresectable or Oligometastatic HCC
- Where
- Beijing
- Életkor
- 18 év and over
- People
- 39
- Run by
- Peking University Cancer Hospital & Institute
See details and how to joinNCT05917431 - No phaseTaking peopleDigitalized Surveillance Management for Liver Cancer Risk Population in Improving Eearly Diagnosis Efficancy in Chinese Population (dSEARCH)
- Where
- Shanghai
- Életkor
- 18 év to 75 év
- People
- 20 000
- Run by
- Ruijin Hospital
See details and how to joinNCT05870969 - 3. fázisTaking peopleAnlotinib Hydrochloride Capsules Combined With Penpulimab Injection for the Treatment of Hepatocellular Carcinoma at High Risk of Recurrence.
- Where
- Baoji, Beijing, Bengbu, Binzhou, Changchun, Changsha, Changzhi, Changzhou, Chengdu, Chifeng, Chongqing, Dalian, Fuzhou, Ganzhou, Guangzhou, Guiyang, Haikou, Hangzhou, Harbin, Hefei, Jinan, Jinzhou, Lanzhou, Luoyang, Luzhou, Nanchang, Nanchong, Nanjing, Nanning, Nantong, Ningbo, Shanghai, Shaoxing, Shenyang, Taizhou, Tianjin, Ürümqi, Wenzhou, Xi'an, Xi’an, Zhengzhou, Zunyi
- Életkor
- 18 év to 75 év
- People
- 480
- Run by
- Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
See details and how to joinNCT05862337 - 2. fázisTaking peopleCombination of Gemcitabine, Albumin-paclitaxel , Sintilimab and Bevacizumab in Unresectable Gallbladder Cancer
- Where
- Shanghai
- Életkor
- 18 év to 75 év
- People
- 50
- Run by
- Lu Wang, MD, PhD
See details and how to joinNCT05757336 - No phaseTaking peoplePrevention of Postoperative Recurrence of Hepatocellular Carcinoma by Blocking RAK Cells With Anti-TIM-3
- Where
- Beijing
- Életkor
- 18 év to 75 év
- People
- 88
- Run by
- Beijing Hospital
See details and how to joinNCT05738980 - No phaseNot yet taking people in KínaAdjuvant Stereotactic Body Radiotherapy (SBRT) for Hepatocellular Carcinoma After Hepatectomy With Narrow Margin: a Prospective, Multi-center, Randomized Controlled, Open-labelled, Phase III Study
- Where
- Hangzhou
- Életkor
- 18 év to 75 év
- People
- 140
- Run by
- Second Affiliated Hospital, Zhejiang University, School of Medicine
See details and how to joinNCT05602974 - 3. fázisNot yet taking people in KínaSBRT Plus Lenvatinib and TACE for Advanced Primary HCC: A Phase 3 Trial (SEARCH)
- Where
- Guangzhou
- Életkor
- 18 év to 75 év
- People
- 136
- Run by
- Sun Yat-sen University
See details and how to joinNCT05718232 - No phaseTaking peopleClinical Outcomes of HBeAg-negative CHB Patients With Indeterminate Phase
- Where
- Changzhou, Huai'an, Nanjing, Suqian, Suzhou
- Életkor
- 18 év and over
- People
- 4500
- Run by
- The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School
See details and how to joinNCT05661786 - No phaseTaking peopleStudy of GPC-3 CAR-T Cells in Treating With Hepatocellular Carcinoma
- Where
- Shenzhen
- Életkor
- 40 év to 70 év
- People
- 20
- Run by
- Shenzhen University General Hospital
See details and how to joinNCT05620706 - No phaseTaking peopleRegional or Extend LymphAdenectomy During Resection of Intrahepatic Cholangiocarcinoma
- Where
- Beijing, Changsha, Chengdu, Guangzhou, Hanzhou, Hohhot, Shanghai, Xi’an
- Életkor
- 18 év to 80 év
- People
- 168 worldwide
- Run by
- Second Affiliated Hospital, Zhejiang University, School of Medicine
See details and how to joinNCT04078230 - 3. fázisTaking peopleLenvatinib Plus I-125 Seed Brachytherapy vs. Lenvatinib for TACE-refractory HCC
- Where
- Guangzhou
- Életkor
- 18 év to 75 év
- People
- 187
- Run by
- Second Affiliated Hospital of Guangzhou Medical University
See details and how to joinNCT05608213 - No phaseTaking peopleAntiviral Therapy for Patients With Liver Cancer After Surgery
- Where
- Changsha
- Életkor
- 18 év to 65 év
- People
- 360
- Run by
- Xiangya Hospital of Central South University
See details and how to joinNCT05466565 - 1/2. fázisTaking peopleStudy Of B7H3 CAR-T Cells in Treating Advanced Liver Cancer
- Where
- Xuzhou
- Életkor
- 18 év to 70 év
- People
- 15
- Run by
- The Affiliated Hospital of Xuzhou Medical University
See details and how to joinNCT05323201 - 1. fázisTaking peopleAnti-CEA CAR-T Cells to Treat Colorectal Liver Metastases
- Where
- Shanghai
- Életkor
- 18 év to 75 év
- People
- 18
- Run by
- Changhai Hospital
See details and how to joinNCT05240950 - No phaseNot yet taking people in KínaNeoadjuvant PDT in the Treatment of Cholangiocarcinoma
- Where
- Xi'an
- Életkor
- 18 év to 75 év
- People
- 50
- Run by
- First Affiliated Hospital Xi'an Jiaotong University
See details and how to joinNCT04824742 - No phaseTaking peopleNeo-TACE-HAIC for High-risk BCLC A Stage HCC (NeoconceptA)
- Where
- Guangzhou
- Életkor
- 18 év to 75 év
- People
- 320
- Run by
- Sun Yat-sen University
See details and how to joinNCT04777942 - 2. fázisTaking peopleRFA Plus Carrizumab vs Carrizumab Alone for HCC
- Where
- Hangzhou
- Életkor
- 18 év to 75 év
- People
- 120
- Run by
- Second Affiliated Hospital, Zhejiang University, School of Medicine
See details and how to joinNCT04150744 - No phaseTaking peopleTo Compare the Efficacy of Microwave Ablation and Laparoscopic Hepatectomy for Hepatocellular Carcinoma
- Where
- Beijing
- Életkor
- 18 év and over
- People
- 1134
- Run by
- Chinese PLA General Hospital
See details and how to joinNCT04365751 - 3. fázisTaking peopleThe Impact on Survival of Neo-adjuvant Transarterial Chemoinfusion (TAI) for Patients With Hepatocellular Carcinoma And Portal Vein Tumor Thrombosis (PVTT) Who Underwent Hepatectomy : A Random, Controlled, Stage III Clinical Trial.
- Where
- Guangzhou
- Életkor
- 18 év to 75 év
- People
- 230
- Run by
- Sun Yat-sen University
See details and how to joinNCT03368651